The report “In-Vitro Colorectal Cancer Screening Tests Market By Product: (Biomarker Tests, Fecal Occult Blood Tests and CRC DNA Screening Tests) – Global Forecast to 2022”, issued by Crystal Market Research, the market has come across substantial development in the recent years and is projected to grow significantly over the forecast period.
Inquire for sample copy at: https://www.crystalmarketresearch.com/report-sample/HC11325
Global In-Vitro Colorectal Cancer Screening Tests Market: Industry Synopsis
The global In-Vitro Colorectal Cancer Screening Tests market was worth USD 0.50 billion in the year 2012 and is expected to reach approximately USD 0.85 billion by 2022, while registering itself at a compound annual growth rate (CAGR) of 5.39% during the forecast period. Developing rates of rectal and colon cancer and the advent of novel screening tests utilizing genetic testing are the key elements that are anticipated to drive the in-vitro colorectal cancer screening tests market over the conjecture time frame. The advent of government controls went for compulsory use of cancer screening tests, increasing requirement for novel minimally invasive tests which screen for colorectal cancer utilizing genetic and DNA biomarkers and the expanding commonness of colorectal disease are foreseen to fuel the development of the market for in-vitro colorectal cancer screening tests. Comprehensively, colorectal cancer (CRC) is the third most common type of cancer. CRC represents right around a tenth of all disease occurrences around the world. This rate has just been expanding in the course of the most recent few years. Moreover, the advent of novel colorectal tests which utilize biomarkers, for example, tumor M2-PK marker or which screen for colorectal disease utilizing methylated genes for screening will witness a development in market demand all through the gauge time frame. The essential factor in charge of this switch in pattern can be ascribed to by the expanded precision of screening which these more up to date genetic tests bring to the table.
Global In-Vitro Colorectal Cancer Screening Tests Market: Competitive Insights
The increasing investment in research and development by the players is triggering competition in the global In-Vitro Colorectal Cancer Screening Tests market.
The in-vitro colorectal cancer screening tests market is extremely focused set apart by constant key partnerships, mergers, and acquisitions. Coordinated efforts are essentially utilized as a technique to upgrade item portfolio. The market is anticipated to move towards union throughout the following years. Research and development spending is relied upon to keep on growing, as most market players are associated with the improvement of CRC DNA and biomarker screening tests. Some of the major players in the market are R-Biopharm, Epigenomics AG, Sysmex Corporation, Quest Diagnostics, Merck Millipore, Kyowa Medex, Companion Dx, Abbott Molecular Inc, Immunostics Co, MODE Diagnostics Ltd, Siemens Healthineers and Randox Laboratories.
The strategic mergers and acquisitions among the players of the global In-Vitro Colorectal Cancer Screening Tests market are leading to the expansion of this market.
Browse Report Description with Complete ToC at: https://www.crystalmarketresearch.com/report/in-vitro-colorectal-cancer-screening-tests-market
The In-Vitro Colorectal Cancer Screening Tests Market is segmented as follows-
By Product: Biomarker Tests( Transferrin Assays & Tumor M2-PK Stool Test), Fecal Occult Blood (Lateral Flow Immuno-FOB Test, Guaiac FOB Stool Test, Immuno-FOB Agglutination Test and Immuno-FOB ELISA Test) and CRC DNA Screening Tests: (Panel DNA Tests and Methylated Gene Testing)
By Region: North America: (U.S, Canada & Mexico), Europe: (Germany, France, UK, Italy, Spain & Rest of Europe), Asia-Pacific: (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific) and Rest of the World: (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates & Others)
Global In-Vitro Colorectal Cancer Screening Tests Market: Regional Analysis:
In 2014 the in-vitro colorectal cancer screening tests market was dominated by North America. Factors, for example, rising aged population, high rates of colorectal cancer has added to the district's market position. Nonetheless, Asia-Pacific is relied upon to witness generous development over the figure time frame attributable to the expanding commonness of cancer in this area. Cancer is a developing concern inferable from rising elderly populace base and changes in way of life in Asian nations. In-vitro colorectal cancer is the third most harmful issue in men and women. The death rates of colorectal cancer are on an ascent in this locale over the previous decade. National rules on colorectal cancer screening are nonexistent in most Asian nations aside from in Taiwan, Singapore, Japan, and Korea.
Reports Enquiry at: https://www.crystalmarketresearch.com/send-an-enquiry/HC11325
Major ToC of Global In-Vitro Colorectal Cancer Screening Tests Market:
Chapter 1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
Chapter 2. Executive Summary
2.1. Key Highlights
Chapter 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Rising Incidence of Rectal and Colon Cancer around the World
3.2.1.2. Enhanced Accuracy of Colorectal Cancer Screening Using Genetic Testing
3.2.1.3. Strong Product Pipeline
3.2.2. Restraints
3.2.2.1. Unfavorable Reimbursement Policies
3.2.2.2. Dearth of Skilled Professionals
3.2.3. Opportunities
3.2.3.1. Emerging Economies to Offer Lucrative Growth Opportunities
Read Premium News from The Open PR of In-Vitro Colorectal Cancer Screening Tests Market at: https://www.openpr.com/news/1251162/In-Vitro-Colorectal-Cancer-Screening-Tests-Market-Crossing-0-85-Billion-Up-to-2022-Major-Market-Demanding-Players-R-Biopharm-Epigenomics-AG-Sysmex-Corporation-Quest-Diagnostics-Merck-Millipore-Kyowa-Medex-Companion-Dx-Abbott-Molecular-Inc-Immu.html .
Chapter 4. In-Vitro Colorectal Cancer Screening Tests Market, By Product
4.1. Introduction
4.2. In-Vitro Colorectal Cancer Screening Tests Market Assessment and Forecast, By Product, 2012-2022
4.3. Fecal Occult Blood Tests
4.3.1. Market Assessment and Forecast, By Type, 2012-2022 ($Million)
4.3.2. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.3.3. Guaiac FOB Stool Test
4.3.3.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.3.4. Lateral Flow Immuno-FOB Test
4.3.4.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.3.5. Immuno-FOB Agglutination Test
4.3.5.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.3.6. Immuno-FOB ELISA Test
4.3.6.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
...
Chapter 5. In-Vitro Colorectal Cancer Screening Tests Market, By Region
Chapter 6. Company Profiles
List of Tables:
Table 1.Global In-Vitro Colorectal Cancer Screening Tests Market, By Product ($Million), 2012-2022
Table 2.Fecal Occult Blood Tests Market, By Type ($Million), 2012-2022
Table 3.Fecal Occult Blood Tests Market, By Region ($Million), 2012-2022
Table 4.Guaiac FOB Stool Test Market, By Region ($Million), 2012-2022
Table 5.Lateral Flow Immuno-FOB Test Market, By Region ($Million), 2012-2022
List of Figures:
Figure 1.Global In-Vitro Colorectal Cancer Screening Tests Market Share, By Product, 2012 & 2022
Figure 2 In-Vitro Colorectal Cancer Screening Tests Market, By Region, 2012 & 2022, ($Million)
Figure 3.Abbott Molecular Inc.: Net Revenues, 2014-2016 ($Million)
Figure 4.Abbott Molecular Inc.: Net Revenue Share, By Segment, 2016
…Read Full Table of Contents
(Early customers will receive 10% customization in this report.)
Avail Quality Discount at: https://www.crystalmarketresearch.com/check-discount/HC11325
About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contacts Us:
Judy | 304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
E-mail: [email protected] | Tel: +1-888-213-4282
Web: https://www.crystalmarketresearch.com
This user is on the @buildawhale blacklist for one or more of the following reasons:
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Submit